Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PJP vs. IYH: which is better?

Bottom line

PJP vs IYH: the short answer

PJP (Invesco Pharmaceuticals ETF) and IYH (iShares U.S. Healthcare ETF) share a meaningful slice of their top holdings — about 40% by weight.

But IYH is far broader, holding 103 positions to 33 for PJP, so beyond the top names it adds exposure PJP doesn't have.

IYH is cheaper at 0.37% vs 0.58% — a difference of $21 a year per $10,000 invested.

Over five years, PJP returned +9.0% a year vs +7.0% for IYH.

Updated Nov 19, 2026

PJP vs IYH side by side

PJPIYH
TypeETFETF
Fund familyInvescoiShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.58%0.37%
Annual cost per $10k$58$37
10-yr cost on $10k (prospectus)$726$468
Max front loadNoneNone
12b-1 fee—0%
1-yr return+27.9%+13.1%
5-yr return (annualized)+9.0%+7.0%
10-yr return (annualized)+5.1%+9.4%
Best quarter+18.1%+15.3%
Worst quarter−14.8%−12.7%
Net assets (fund)$472.1M$3.6B
Number of holdings33103
Portfolio turnover36%3%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPJPIYHDifference
2025+27.9%+13.1%+14.8%
2024+9.7%+3.1%+6.6%
2023−2.2%+2.1%−4.3%
2022−2.0%−4.4%+2.4%
2021+14.5%+23.4%−8.9%
2020+11.2%+15.5%−4.3%
2019+4.7%+20.8%−16.1%
2018−1.7%+5.9%−7.6%
2017+15.3%+22.3%−7.0%
2016−19.3%−2.8%−16.4%

Source: Fund prospectus bar charts

Holdings overlap

10 of PJP's top 25 holdings also appear in IYH's top 25.

Shared top holdings
HoldingPJPIYH
Abbott Laboratories5.67%3.02%
AbbVie Inc.5.48%7.32%
Amgen Inc.5.33%3.42%
Johnson & Johnson5.18%10.17%
Merck & Co., Inc.5.06%5.31%
Eli Lilly and Co.5.02%15.11%
Gilead Sciences, Inc.4.53%2.66%
Pfizer Inc.4.50%2.35%
Regeneron Pharmaceuticals, Inc.3.14%1.27%
Bristol-Myers Squibb Co.2.94%2.20%

Source: SEC Form N-PORT

PJP top 10

  1. Invesco Private Prime Fund — 7.93%
  2. Abbott Laboratories — 5.67%
  3. AbbVie Inc. — 5.48%
  4. Amgen Inc. — 5.33%
  5. Johnson & Johnson — 5.18%
  6. Merck & Co., Inc. — 5.06%
  7. Eli Lilly and Co. — 5.02%
  8. Corcept Therapeutics Inc. — 4.96%
  9. Gilead Sciences, Inc. — 4.53%
  10. Pfizer Inc. — 4.50%

IYH top 10

  1. Eli Lilly And Company — 15.11%
  2. Johnson & Johnson — 10.17%
  3. Abbvie Inc. — 7.32%
  4. Unitedhealth Group Incorporated — 6.16%
  5. Merck & Co., Inc. — 5.31%
  6. Thermo Fisher Scientific Incorporated — 3.52%
  7. Amgen Inc. — 3.42%
  8. Abbott Laboratories — 3.02%
  9. Gilead Sciences, Inc. — 2.66%
  10. Pfizer Inc. — 2.35%

FAQ

What is the difference between PJP and IYH?
PJP (Invesco Pharmaceuticals ETF) and IYH (iShares U.S. Healthcare ETF) share a meaningful slice of their top holdings — about 40% by weight. But IYH is far broader, holding 103 positions to 33 for PJP, so beyond the top names it adds exposure PJP doesn't have.
Which is cheaper, PJP or IYH?
IYH has the lower expense ratio (0.37%).
Should I own both PJP and IYH?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.